Energy metabolism in osteoclast formation and activity

International Journal of Biochemistry and Cell Biology

Volumn 79, Issue , 2016, Pages 168-180

  Lemma, Silvia ^a,b   Sboarina, Martina ^c   Porporato, Paolo E ^c   Zini, Nicoletta ^a,d   Sonveaux, Pierre ^c   Di Pompo, Gemma ^a   Baldini, Nicola ^a,b   Avnet, Sofia ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^d CNR   (Italy)

Author keywords

Differentiation; Energy metabolism; Glycolytic efficiency; Mitochondria; Osteoclast

Indexed keywords

ACTIN; COLLAGEN TYPE 1; GALACTOSE; ROTENONE;

AEROBIC METABOLISM; ARTICLE; BONE MATRIX; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRION; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; QUANTITATIVE ANALYSIS; RESPIRATORY CHAIN; SUPERNATANT; CYTOLOGY; METABOLISM; MITOCHONDRIAL VOLUME;

CELL DIFFERENTIATION; COLLAGEN TYPE I; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MITOCHONDRIAL SIZE; OSTEOCLASTS;

EID: 84984799189     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2016.08.034     Document Type: Article

References (54)

1. Archer, S.L., Mitochondrial dynamics?mitochondrial fission and fusion in human diseases. N. Eng. J. Med. 369 (2013), 2236–2251, 10.1056/NEJMra1215233.
2. Arnett, T.R., Acidosis, hypoxia and bone. Arch. Biochem. Biophys. 503 (2010), 103–109, 10.1016/j.abb.2010.07.021.
3. Avnet, S., Longhi, A., Salerno, M., Halleen, J.M., Perut, F., Granchi, D., Ferrari, S., Bertoni, F., Giunti, A., Baldini, N., Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int. J. Oncol. 33 (2008), 1231–1238.
4. Avnet, S., Salerno, M., Quacquaruccio, G., Granchi, D., Giunti, A., Baldini, N., IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. Exp. Cell. Res. 327 (2011), 2147–2158, 10.1016/j.yexcr.2011.05.030.
5. Avnet, S., Salerno, M., Zini, N., Alberghini, M., Gibellini, D., Baldini, N., Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone. Am. J. Pathol. 182 (2013), 1357–1366, 10.1016/j.ajpath.2012.12.021.
6. Baron, R., Neff, L., Tran Van, P., Nefussi, J.R., Vignery, A., Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am. J. Pathol. 122 (1986), 363–378.
7. Blair, J.M., Zheng, Y., Dunstan, C.R., RANK ligand. Int. J. Biochem. Cell Biol. 39 (2007), 1077–1081, 10.1016/j.biocel.2006.11.008.
8. Boyle, W.J., Simonet, W.S., Lacey, D.L., Osteoclast differentiation and activation. Nature 423 (2003), 337–342, 10.1038/nature01658.
9. Cenni, E., Perut, F., Granchi, D., Amato, I., Avnet, S., Brandi, M.L., Giunti, A., Baldini, N., Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells. Anticancer Res. 26 (2006), 3065–3069.
10. Cipriano, D.J., Wang, Y., Bond, S., Hinton, A., Jefferies, K.C., Qi, J., Forgac, M., Structure and regulation of the vacuolar ATPases. Biochim. Biophys. Acta 1777 (2008), 599–604, 10.1016/j.bbabio.2008.03.013.
11. Czupalla, C., Mansukoski, H., Pursche, T., Krause, E., Hoflack, B., Comparative study of protein and mRNA expression during osteoclastogenesis. Proteomics 5 (2005), 3868–3875, 10.1002/pmic.200402059.
12. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B.W., Cantelmo, A.R., Quaegebeur, A., Ghesquiere, B., Cauwenberghs, S., Eelen, G., Phng, L.K., Betz, I., Tembuyser, B., Brepoels, K., Welti, J., Geudens, I., Segura, I., Cruys, B., Bifari, F., Decimo, I., Blanco, R., Wyns, S., Vangindertael, J., Rocha, S., Collins, R.T., Munck, S., Daelemans, D., Imamura, H., Devlieger, R., Rider, M., Van Veldhoven, P.P., Schuit, F., Bartrons, R., Hofkens, J., Fraisl, P., Telang, S., Deberardinis, R.J., Schoonjans, L., Vinckier, S., Chesney, J., Gerhardt, H., Dewerchin, M., Carmeliet, P., Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154 (2013), 651–663, 10.1016/j.cell.2013.06.037.
13. Demetrius, L., Aging in mouse and human systems: a comparative study. Ann. N. Y. Acad. Sci. 1067 (2006), 66–82, 10.1196/annals.1354.010.
14. Erzurumlu, Y., Kose, F.A., Gozen, O., Gozuacik, D., Toth, E.A., Ballar, P., A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization. Int. J. Biochem. Cell Biol. 45 (2013), 773–782, 10.1016/j.biocel.2013.01.006.
15. Francis, M.J., Lees, R.L., Trujillo, E., Martin-Vasallo, P., Heersche, J.N., Mobasheri, A., ATPase pumps in osteoclasts and osteoblasts. Int. J. Biochem. Cell Biol. 34 (2002), 459–476.
16. Frangini, M., Franzolin, E., Chemello, F., Laveder, P., Romualdi, C., Bianchi, V., Rampazzo, C., Synthesis of mitochondrial DNA precursors during myogenesis, an analysis in purified C2C12 myotubes. J. Biol. Chem. 288 (2013), 5624–5635, 10.1074/jbc.M112.441147.
17. Gilkerson, R.W., Selker, J.M., Capaldi, R.A., The cristal membrane of mitochondria is the principal site of oxidative phosphorylation. FEBS Lett. 546 (2003), 355–358.
18. Granchi, D., Amato, I., Battistelli, L., Avnet, S., Capaccioli, S., Papucci, L., Donnini, M., Pellacani, A., Brandi, M.L., Giunti, A., Baldini, N., In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int. J. Cancer 111 (2004), 829–838, 10.1002/ijc.20308.
19. Granchi, D., Amato, I., Battistelli, L., Ciapetti, G., Pagani, S., Avnet, S., Baldini, N., Giunti, A., Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials 26 (2005), 2371–2379, 10.1016/j.biomaterials.2004.07.045.
20. Indo, Y., Takeshita, S., Ishii, K.A., Hoshii, T., Aburatani, H., Hirao, A., Ikeda, K., Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res. 28 (2013), 2392–2399, 10.1002/jbmr.1976.
21. Ishii, K.A., Fumoto, T., Iwai, K., Takeshita, S., Ito, M., Shimohata, N., Aburatani, H., Taketani, S., Lelliott, C.J., Vidal-Puig, A., Ikeda, K., Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med. 15 (2009), 259–266, 10.1038/nm.1910.
22. Jin, Z., Wei, W., Yang, M., Du, Y., Wan, Y., Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab. 20 (2014), 483–498, 10.1016/j.cmet.2014.07.011.
23. Kase, E.T., Nikolic, N., Bakke, S.S., Bogen, K.K., Aas, V., Thoresen, G.H., Rustan, A.C., Remodeling of oxidative energy metabolism by galactose improves glucose handling and metabolic switching in human skeletal muscle cells. PLoS One, 8, 2013, e59972, 10.1371/journal.pone.0059972.
24. Kim, J.M., Jeong, D., Kang, H.K., Jung, S.Y., Kang, S.S., Min, B.M., Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell. Physiol. Biochem. 20 (2007), 935–946, 10.1159/000110454.
25. Knowles, H.J., Athanasou, N.A., Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J. Pathol. 218 (2009), 256–264, 10.1002/path.2534.
26. Knowles, H.J., Cleton-Jansen, A.M., Korsching, E., Athanasou, N.A., Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J. 24 (2010), 4648–4659, 10.1096/fj.10-162230.
27. Komarova, S.V., Ataullakhanov, F.I., Globus, R.K., Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am. J. Physiol. Cell Physiol. 279 (2000), C1220–1229.
28. Lakkakorpi, P.T., Vaananen, H.K., Cytoskeletal changes in osteoclasts during the resorption cycle. Microsc. Res. Tech. 33 (1996), 171–181, 10.1002/(SICI)1097-0029(19960201)33:2<171:AID-JEMT7>3.0.CO; 2-W.
29. Loftus, R.M., Finlay, D.K., Immunometabolism: cellular metabolism turns immune regulator. J. Biol. Chem. 291 (2016), 1–10, 10.1074/jbc.R115.693903.
30. Lu, M., Holliday, L.S., Zhang, L., Dunn, W.A. Jr., Gluck, S.L., Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J. Biol. Chem. 276 (2001), 30407–30413, 10.1074/jbc.M008768200.
31. Massey, H.M., Flanagan, A.M., Human osteoclasts derive from CD14-positive monocytes. Br. J. Haematol. 106 (1999), 167–170.
32. Miyazaki, T., Iwasawa, M., Nakashima, T., Mori, S., Shigemoto, K., Nakamura, H., Katagiri, H., Takayanagi, H., Tanaka, S., Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption. J. Biol. Chem. 287 (2012), 37808–37823, 10.1074/jbc.M112.385369.
33. Morrison, M.S., Turin, L., King, B.F., Burnstock, G., Arnett, T.R., ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J. Physiol. 511:Pt 2 (1998), 495–500.
34. Morten, K.J., Badder, L., Knowles, H.J., Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J. Pathol. 229 (2013), 755–764, 10.1002/path.4159.
35. Mulari, M.T., Zhao, H., Lakkakorpi, P.T., Vaananen, H.K., Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4 (2003), 113–125.
36. Novack, D.V., Role of NF-kappaB in the skeleton. Cell Res. 21 (2011), 169–182, 10.1038/cr.2010.159.
37. Pavlova, N.N., Thompson, C.B., The emerging hallmarks of cancer metabolism. Cell Metab. 23 (2016), 27–47, 10.1016/j.cmet.2015.12.006.
38. Qin, A., Cheng, T.S., Pavlos, N.J., Lin, Z., Dai, K.R., Zheng, M.H., V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Int. J. Biochem. Cell Biol. 44 (2012), 1422–1435, 10.1016/j.biocel.2012.05.014.
39. Rossignol, R., Gilkerson, R., Aggeler, R., Yamagata, K., Remington, S.J., Capaldi, R.A., Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64 (2004), 985–993.
40. Silver, I.A., Murrills, R.J., Etherington, D.J., Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell. Res. 175 (1988), 266–276.
41. Sun, S.C., The noncanonical NF-kappaB pathway. Immunol. Rev. 246 (2012), 125–140, 10.1111/j.1600-065X.2011.01088. x.
42. Sweeney, S.E., Firestein, G.S., Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36 (2004), 372–378.
43. Teitelbaum, S.L., Bone resorption by osteoclasts. Science 289 (2000), 1504–1508.
44. Touaitahuata, H., Planus, E., Albiges-Rizo, C., Blangy, A., Pawlak, G., Podosomes are dispensable for osteoclast differentiation and migration. Eur. J. Cell Biol. 92 (2013), 139–149, 10.1016/j.ejcb.2013.03.001.
45. Utting, J.C., Flanagan, A.M., Brandao-Burch, A., Orriss, I.R., Arnett, T.R., Hypoxia stimulates osteoclast formation from human peripheral blood. Cell Biochem. Funct. 28 (2010), 374–380, 10.1002/cbf.1660.
46. Wei, W., Wang, X., Yang, M., Smith, L.C., Dechow, P.C., Sonoda, J., Evans, R.M., Wan, Y., PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab. 11 (2010), 503–516, 10.1016/j.cmet.2010.04.015.
47. Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G.M., Budinger, G.R., Chandel, N.S., Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 8788–8793, 10.1073/pnas.1003428107.
48. Williams, J.P., Blair, H.C., McDonald, J.M., McKenna, M.A., Jordan, S.E., Williford, J., Hardy, R.W., Regulation of osteoclastic bone resorption by glucose. Biochem. Biophys. Res. Commun. 235 (1997), 646–651, 10.1006/bbrc.1997.6795.
49. Wu, K., Aoki, C., Elste, A., Rogalski-Wilk, A.A., Siekevitz, P., The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 13273–13278.
50. Zala, D., Hinckelmann, M.V., Yu, H., Lyra da Cunha, M.M., Liot, G., Cordelieres, F.P., Marco, S., Saudou, F., Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152 (2013), 479–491, 10.1016/j.cell.2012.12.029.
51. Zancan, P., Sola-Penna, M., Furtado, C.M., Da Silva, D., Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab. 100 (2010), 372–378, 10.1016/j.ymgme.2010.04.006.
52. Zeng, R., Faccio, R., Novack, D.V., Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms. J. Bone Miner. Res. 30 (2015), 2287–2299, 10.1002/jbmr.2584.
53. Zhou, J., Ye, S., Fujiwara, T., Manolagas, S.C., Zhao, H., Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation. J. Biol. Chem. 288 (2013), 30064–30074, 10.1074/jbc.M113.478750.
54. Zini, N., Avnet, S., Ghisu, S., Maraldi, N.M., Squarzoni, S., Baldini, N., Lattanzi, G., Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts. J. Cell. Biochem. 105 (2008), 34–40, 10.1002/jcb.21796.